Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-08 Purchase | 2022-06-10 6:24 pm | Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Commercial Officer | 28,200 | $0.71 | $20,022 | 36,200 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-20 Option Award | 2024-05-22 5:19 pm | N/A 2034-05-19 | Alto Neuroscience Inc. | ANRO | Hanley Jr. Michael Conick Chief Operating Officer | 188,000 | $0 | 188,000 (Direct) | View |
Ownership | 2024-05-22 5:17 pm | N/A 2034-02-28 | Alto Neuroscience Inc. | ANRO | Hanley Jr. Michael Conick Chief Operating Officer | 0 | $0 | 8,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-24 6:22 pm | N/A 2033-02-22 | Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Business Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-08-23 Option Award | 2022-08-25 7:35 pm | N/A 2032-08-22 | Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Business Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 4:51 pm | N/A 2032-02-16 | Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Commercial Officer | 160,000 | $0 | 160,000 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 5:07 pm | N/A 2031-02-16 | Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Commercial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 5:12 pm | N/A 2030-02-13 | Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Commercial Officer | 25,000 | $0 | 25,000 (Direct) | View |